← All Sponsors
SPONSOR

Eilean Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Type 2 Diabetes
NCT07234864 Phase 1
Recruiting

Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.

Type 2 Diabetes
Australia, Uzbekistan View Trial →